Advanced Practice Provider (NP or PA) — Rheumatology: Osteoporosis & Bone Health

We are seeking a Nurse Practitioner or Physician Assistant to lead and grow a dedicated Osteoporosis & Bone Health program within our rheumatology practice.

This is a specialty focused role: the APP will serve as the primary clinician for metabolic bone disease patients, operating with a high degree of autonomy under the supervision/collaboration of a board certified rheumatologist.

The role combines direct patient care, infusion and injectable therapy management, fracture prevention program development, and care coordination with referring specialties (orthopedics, endocrinology, primary care, oncology, and women’s health).

This is a hybrid role combining on-site and telemedicine care. In-person days center on new consults, infusion/injection oversight, and procedures; telemedicine sessions cover follow-ups, DXA and lab result reviews, medication monitoring, and adherence check-ins.

This structure allows the APP to serve patients across multiple sites and geographies while maintaining a hands-on clinical anchor.

This position is ideal for an APP who wants true subspecialty ownership — building a Bone Health Center of Excellence rather than functioning as general clinic overflow.

Key Responsibilities

Clinical Care

Serve as primary provider for osteoporosis, osteopenia, and metabolic bone disease patients (new consults and ongoing management) Perform comprehensive fracture risk assessment, including FRAX scoring and fall risk evaluation Order DXA scans and review results with the supervising rheumatologist; track serial studies and follow-up compliance Conduct secondary osteoporosis workups (celiac disease, hyperparathyroidism, vitamin D deficiency, hypogonadism, monoclonal gammopathy, glucocorticoid-induced osteoporosis, etc.)

Initiate and manage the full pharmacologic spectrum: bisphosphonates (oral and IV zoledronic acid), denosumab, romosozumab, teriparatide, and abaloparatide — including anabolic-to-antiresorptive sequencing and denosumab discontinuation/transition planning Manage glucocorticoid-induced osteoporosis in the rheumatology population (RA, PMR, lupus, vasculitis patients on chronic steroids) Monitor laboratory safety parameters; manage adverse effects and treatment holidays appropriately Provide pre-treatment dental clearance coordination and counsel patients on ONJ and atypical femoral fracture risk Infusion & Injection Program Oversee clinical protocols for in-office IV zoledronic acid infusions and subcutaneous denosumab/romosozumab administration Train and supervise clinical staff (MAs/RNs) on injection administration, documentation, and adherence tracking Build recall and adherence workflows so no patient misses a denosumab dose window or falls off therapy silently Program Development Help design and operate a Fracture Liaison Service (FLS)–style pathway: identify post fracture patients from referring orthopedic and hospital partners and close the treatment gap Develop standardized EMR templates, order sets, and patient education materials for bone health visits Track program metrics: treatment initiation rates post-fracture, DXA follow-up compliance, adherence/persistence rates, and patient attrition recovery Participate in community and referring-provider education (lunch-and-learns, PCP outreach) to grow the program Telemedicine Care Delivery Conduct virtual follow-up visits for established bone health patients: DXA and lab review, therapy titration, adherence and side-effect check-ins, and treatment-holiday monitoring Triage which patients require in-person evaluation vs. virtual management, and maintain appropriate documentation standards for telehealth encounters Use virtual visits to extend the program’s reach to patients at distant sites, homebound patients, and post-fracture patients who struggle to travel Collaboration Work under a collaborative/supervisory agreement with the practice rheumatologist(s), with structured case review for complex patients Coordinate with specialty pharmacy on prior authorizations, benefits investigation, and patient assistance programs for branded therapies Communicate closely with referring providers to keep them engaged in shared patients’ care

Requirements

Required

Current, unrestricted state licensure as an NP (FNP or AGNP) or PA-C National board certification (AANP/ANCC or NCCPA) Active DEA registration or eligibility 2+ years of clinical experience as an APP (rheumatology, endocrinology, orthopedics, geriatrics, or women’s health strongly preferred) Comfort managing injectable and infusion therapies Strong EMR proficiency and willingness to build/refine templates and workflows Comfort and professionalism delivering care via telemedicine, including virtual patient

Education

Preferred

Direct experience managing osteoporosis pharmacotherapy, including anabolic agents Experience with Fracture Liaison Services or bone health program development Familiarity with prior authorization and specialty pharmacy processes Interest in clinical research; opportunity to serve as sub-investigator on bone health and rheumatology trials

What We Offer

True subspecialty focus with program ownership and direct mentorship from a rheumatologist Support for CME and continuing education in metabolic bone disease Opportunity to shape a Bone Health Center of Excellence from the ground up, including quality metrics and program design Hybrid schedule blending on-site clinical days with dedicated telemedicine sessions Competitive salary with productivity/program-growth incentives, full benefits, malpractice coverage, and paid CME time Optional pathway into clinical research participation (sub-investigator roles)

Reporting Structure

Reports clinically to the supervising/collaborating rheumatologist and operationally to the practice/clinic administrator.

Compensation, schedule, and location details to be finalized based on candidate experience and site.